MyFinsight
Home
About
Contact
dmac: the income statement
Download
Download image
Net loss and
comprehensive loss
-$8,556K
Unrealized gain on
marketable securities
$64K
Net loss
-$8,620K
Income tax expense
$6K
Loss before income
tax expense
-$8,614K
Other income, net
$419K
Operating loss
-$9,033K
General and
administrative
$2,596K
Research and development
$6,437K
Back
Back
Income Statement
source: myfinsight.com
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)